To our knowledge, as anti- PD-1/PD-L1 had attained considerable clinical efficacy in various cancer types, the relationship between IRAK1 and PD-1/PD-L1 axis remains unknown, which motivated us to explore the role of IRAK1 in PD-L1 regulation. This evidence concerns the gene IRAK1 and cancer.